FOUNTAIN INN, S.C., Dec. 1, 2015 (GLOBE NEWSWIRE) -- AVX Corporation, a leading manufacturer of passive components and interconnect solutions, has released its new TBC Series HRC6000 medical implantable grade tantalum capacitors. Delivering lower DC leakage (DCL) values than any competitive offering — down to 0.0025CV or 25% of typical industry limits — and requiring significantly less voltage de-rating than the standard 50% recommendation for solid tantalum capacitors — as low as 20% for filtering and 0% for pacing, hold-up, and charging — the series is ideal for medical implantable and life support applications.
TBC Series HRC6000 capacitors are manufactured using AVX's patented Q-Process, which was developed to replace the Weibull Reliability Assessment as the industry standard for tantalum capacitors due to its tendency to burn-in potentially unstable units. In use since 2013, the Q-Process, which has enhanced screening imbedding in it, effectively removes components that may experience parametric shifts through customer processing or display instability through life testing, ensures stable and normalized DCL distribution, and provides reliability level verification through life testing to a minimum of 0.1% per 1,000 hours with a 90% confidence level.
"The TBC HRC6000 medical grade series is the next generation of our internally qualified medical grade tantalum capacitors," said Brian Brunette, high reliability tantalum applications engineer, AVX. "Manufactured and screened using our patented Q-Process, which utilizes a product level designation system based on a simulated production routine performed on a sample population and a calculation that is both based on the performance of the sample and takes the application conditions of end customers into account, this system allows for remarkably relaxed de-rating recommendations."
Currently available in three case sizes (0603, 0805, and 1411), three rated voltages (4V, 6V, and 10V), three capacitance tolerances (±5%, ±10%, and ±20%), and with capacitance values spanning 2.2μF to 68μF, the series is rated for use in operating temperatures ranging from -55°C to +125°C. At present, 0603 size components are available rated for 2.2μF to 4.7μF and all three voltages, 0805 components are available rated for 6.8μF to 22μF and all three voltages, and 1411 components are available rated for 33μF to 68μF and two voltages: 6V and 10V. TBC Series HRC6000 medical implantable grade capacitors are also available with one of three termination finishes: solder fused, gold-plated, and 100% matte tin, the latter two of which are lead-free compatible and RoHS compliant. Lead time for the series is 12 weeks, and components can be shipped in bulk, on 7" tape and reel, or in waffle packaging.
TBC Series HRC6000 capacitors are manufactured, reliability graded, and function tested in the AVX Biddeford, Maine factory, which is ISO 13485 certified. For more information about this certification, or to request a specific rating, please contact the factory by calling 207-282-5111.
For more information about AVX's new TBC Series HRC6000 medical implantable grade tantalum capacitors, please visit http://datasheets.avx.com/AVX-TBC_HRC6000.pdf to access the product datasheet. For additional information about AVX's patented Q-Process, please visit http://www.avx.com/docs/techinfo/Qprocess.pdf to view the technical publication, "Reaching the Highest Reliability for Tantalum Capacitors." For information about moisture sensitivity levels, please refer to the High Reliability Tantalum MSL section (page 141) of AVX's High Reliability Tantalum Capacitors Catalog located at http://catalogs.avx.com/HighReliabilityTantalum.pdf. For all other inquiries, please visit www.avx.com, call 864-967-2150, or write to One AVX Boulevard, Fountain Inn, S.C. 29644.
AVX Corporation is a leading international supplier of electronic passive components and interconnect solutions with 20 manufacturing and warehouse facilities in 11 countries around the world. AVX offers a broad range of devices including capacitors, resistors, filters, timing and circuit protection devices, and connectors. The company is publicly traded on the New York Stock Exchange (NYSE:AVX).
A photo accompanying this release is available at: http://www.globenewswire.com/newsroom/prs/?pkgid=37914
CONTACT: Brian Brunette Applications Engineer, AVX 207-286-2181 email@example.com Christine Stieglitz PR Executive, BtB Marketing 919-872-8172 firstname.lastname@example.orgSource:AVX Corporation